Sheena Bhalla, M.D. Assistant Professor School Medical School Department Internal Medicine You have reached the Academic Profile. For more information on the doctor and patient care, please visit the clinical profile. Biography Sheena Bhalla, M.D., is an Assistant Professor in the Department of Internal Medicine at UT Southwestern Medical Center, and a member of its Division of Hematology and Oncology. She specializes in thoracic malignancies, including non-small cell lung cancer, small cell lung cancer, mesothelioma, and thymoma. Originally from Florida, Dr. Bhalla holds a bachelor’s degree in brain and cognitive science from the Massachusetts Institute of Technology in Cambridge, Massachusetts. She earned her medical degree at the University of Florida College of Medicine in Gainesville. She completed internal medicine residency training and a fellowship in medical oncology at the Icahn School of Medicine at Mount Sinai in New York. Certified by the American Board of Internal Medicine in medical oncology and hematology, Dr. Bhalla joined the UT Southwestern faculty in 2021. Dr. Bhalla is a member of the American Society of Clinical Oncology and the International Association for the Study of Lung Cancer. Dr. Bhalla has published numerous articles in her key areas of research, which include lung cancer, clinical trials, and cancer care delivery. Education Medical School University of Florida College of Medicine (2015) Residency Icahn School of Medicine at Mount Sinai (2018), Internal Medicine Fellowship Icahn School of Medicine at Mount Sinai (2021), Hematology Oncology Research Interest Cancer Care Delivery Clinical Trials Lung Cancer Publications Featured Publications Geographic Accessibility and Completion of Initial Low-Dose CT-Based Lung Cancer Screening in an Urban Safety-Net Population. Yi S, Rathod RA, Natchimuthu VS, Bhalla S, Lee JL, Browning T, Adesina JO, Do M, Balis D, de Wiliams JG, Kitchell E, Santini NO, Johnson DH, Hamann HA, Lee SJC, Hughes AE, Gerber DE, J Natl Compr Canc Netw 2024 Apr 1-7 Effect of Patient Navigation on Completion of Lung Cancer Screening in Vulnerable Populations. Bhalla S, Natchimuthu V, Lee JL, Wahid U, Zhu H, Santini NO, Browning T, Hamann HA, Johnson DH, Chiu H, Craddock Lee SJ, Gerber DE, J Natl Compr Canc Netw 2024 Mar 1-7 Incidence, Correlates, and Prognostic Significance of Mixed Response in Advanced Non-small Cell Lung Cancer. Gerber DE, Wang Y, Ramalingam SS, Bhalla S, Sun Z, Borghaei H, Brahmer JR, Schiller JH, Oncologist 2024 Jan Emerging Strategies in Lung Cancer Screening: Blood and Beyond. Bhalla S, Yi S, Gerber DE, Clin Chem 2024 Jan 70 1 60-67 Contemporary Trends in Reviewing Test Results Through the Electronic Patient Portal Among Patients With Cancer. Bhalla S, Prasad T, Xie D, Gerber DE, JAMA Oncol 2023 Nov Phase 1 trial of bemcentinib (BGB324), a first-in-class, selective AXL inhibitor, with docetaxel in patients with previously treated advanced non-small cell lung cancer. Bhalla S, Fattah FJ, Ahn C, Williams J, Macchiaroli A, Padro J, Pogue M, Dowell JE, Putnam WC, McCracken N, Micklem D, Brekken RA, Gerber DE, Lung Cancer 2023 Aug 182 107291 Assessing Barriers and Facilitators to Lung Cancer Screening: Initial Findings from a Patient Navigation Intervention. Lee SJC, Lee J, Zhu H, Chen PM, Wahid U, Hamann HA, Bhalla S, Cardenas RC, Natchimuthu VS, Johnson DH, Santini NO, Patel HR, Gerber DE, Popul Health Manag 2023 Jun 26 3 177-184 AXL Inhibitors: Status of Clinical Development. Bhalla S, Gerber DE, Curr Oncol Rep 2023 May 25 5 521-529 Care disruptions among patients with lung cancer: A COVID-19 and cancer outcomes study. Bhalla S, Bakouny Z, Schmidt AL, Labaki C, Steinharter JA, Tremblay DA, Awad MM, Kessler AJ, Haddad RI, Evans M, Busser F, Wotman M, Curran CR, Zimmerman BS, Bouchard G, Jun T, Nuzzo PV, Qin Q, Hirsch L, Feld J, Kelleher KM, Seidman D, Huang HH, Anderson-Keightly HM, El Zarif T, Abou Alaiwi S, Rosenbloom TD, Stewart PS, Galsky MD, Choueiri TK, Doroshow DB, Lung Cancer 2021 Jul 160 78-83 PD-L1 as a biomarker of response to immune-checkpoint inhibitors. Doroshow DB, Bhalla S, Beasley MB, Sholl LM, Kerr KM, Gnjatic S, Wistuba II, Rimm DL, Tsao MS, Hirsch FR, Nat Rev Clin Oncol 2021 06 18 6 345-362 Results 1-10 of 22 1 2 3 Next Last Honors & Awards Chief FellowIcahn School of Medicine at Mount Sinai (2020-2021) Student Teaching AwardIcahn School of Medicine at Mount Sinai (2017) Alpha Omega Alpha Medical Honor SocietyUniversity of Florida College of Medicine (2015) Professional Associations/Affiliations American Society of Clinical Oncology (2018) International Association for the Study of Lung Cancer (2021)
